MTNB Matinas BioPharma: Nilai Bisnis

The visualization of Matinas BioPharma (MTNB) market value, which reached 1.00, is based on the success of the LNC delivery system, which reduces drug toxicity, and expectations surrounding oral amphotericin B trials. High authority within the scientific community sustains shareholder interest in clinical trials. Looking ahead, Matinas BioPharma (MTNB) plans global expansion by scaling the licensing of its software to capture new market segments.

MTNB (Matinas BioPharma Holdings, Inc.) riwayat Nilai Total Perusahaan saka 23.11.2025 nganti 28.10.2026

Matinas BioPharma Holdings (MTNB) - rincian metrik lan laporan keuangan

- rega lan prakiraan konsensus rega:

Rega Matinas BioPharma Holdings, Inc.|MTNB - Bagan rega target

- data kapitalisasi pasar:

Kapitalisasi pasar Matinas BioPharma|MTNB - Nilai Perusahaan

- data kapitalisasi buku:

Aset Bersih saben Siji Saham Matinas BioPharma|MTNB - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Aset Bersih matinasbiopharma.com|MTNB - Total Aset Perusahaan

- data utang lan likuiditas:

Rasio Kabeh Utang marang Dana Pribadi Matinas BioPharma|MTNB - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Matinas BioPharma Holdings, Inc.|MTNB - Utang perusahaan|Rasio utang marang aset resik Matinas BioPharma|MTNB - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Matinas BioPharma

Analisis komprehensif perusahaan:Matinas BioPharma (MTNB)

Assessing the financial stability of Matinas BioPharma (MTNB) requires an analysis of the enterprise value, which combines market capitalization and net debt. Historical EV trends reflect the actual cost of acquiring the company, confirming the efficiency of capital management during the development of the LNC platform and the protection of intellectual property, allowing investors to distinguish the asset's fundamental value from temporary market fluctuations.

Analisis pesaing Matinas BioPharma

Ascendis Pharma AS - Total Nilai Bisnis|Madrigal Pharma (MDGL) - Nilai Total Perusahaan|CORT - Nilai Bisnis|Rhythm Pharmaceuticals (RYTM) - Nilai Perusahaan|AKRO (akerotx.com) - Nilai Total Perusahaan|Nilai Total Perusahaan Metsera MTSR|Nilai Wutuh Bisnis MoonLake Immunotherapeutics AG|Crinetics Pharma (CRNX) - Nilai Perusahaan|Nilai Dipunlarasaken Utang lan Kas NewAmsterdam Pharma Corp (NAMS)|Nilai Perusahaan SLNO (Soleno Therapeutics)|amicusrx.com - Nilai Perusahaan|Nilai Total Perusahaan 89bio (ETNB)|AGIO: Nilai Dipunlarasaken Utang lan Kas|GPCR (Structure Pharma) - Nilai Total Perusahaan|MiMedx Corp (MDXG) - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|RZLT (Rezolute, Inc.) - Nilai Perusahaan|Nilai Perusahaan lexpharma.com (LXRX)|MBX Biosciences (MBX) - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Nilai Dipunlarasaken Utang lan Kas ALT (Altimmune Inc)|Aardvark Therapeutics Corp - Nilai Total Perusahaan|Rega Nyata Tumbas Perusahaan Kanthi Wutuh Sagimet Biosciences Inc SGMT|BIOA (BioAge Labs, Inc.) - Nilai Perusahaan|biomeafusion.com (BMEA) - Total Nilai Perusahaan|QNCX - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Fractyl Health Inc. (GUTS) - Total Nilai Bisnis|VTVT (vTv Therapeutics, Inc.) - Nilai Perusahaan|Nilai Perusahaan Agape ATP Corp.|Nilai Perusahaan Pluri Inc. (PLUR)|Nilai Total Perusahaan SYBX (synlogictx.com)|LPCN: Nilai Total Perusahaan|sprucebiosciences.com - Total Nilai Perusahaan|GLTO - Nilai Total Perusahaan|CTCX - Nilai Total Perusahaan|Lumos Pharma, Inc. - Nilai Perusahaan|ONVO (organovo.com) - Rega Tumbas Perusahaan|RDUS: Nilai Total Perusahaan